106years
（Founded in 1920）
100years
* Over 100 years
Top share in Japan
Leading Company
※In-house estimate
96%
71.1 billion yen
（FY2025）
1611
（End of FY2025）
57
Including 34 international site
8.2％
8.0％
40％
（Benchmark ratio） *Progressive dividend policy adopted *Both policies effective from FY2026
7.0 billion yen
(FY2025) *ASKA Pharmaceutical
Ratio of female employees*1
34.7％
Ratio of female management positions
14.3％
Ratio of female management candidates
20.7％
(End of FY2025 in ASKA Pharmaceutical)
Initiatives to Promote the Advancement of Women
100.0％
（FY2025 in ASKA Pharmaceutical)
55.3％
* The rate in FY2025 compared with the rate in FY2013
Decarbonization Initiatives